LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
29.89
-2.05 (-6.42%)
At close: Nov 25, 2025, 4:00 PM EST
29.88
-0.01 (-0.03%)
After-hours: Nov 25, 2025, 4:04 PM EST
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $935.26 million as of November 25, 2025. Its market cap has increased by 4.54% in one year.
Market Cap
935.26M
Enterprise Value
734.04M
1-Year Change
4.54%
Ranking
Category
Stock Price
$29.89
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has increased from $413.64M to $935.26M, an increase of 126.10%. That is a compound annual growth rate of 62.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 999.40M | 25.88% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.20B |
| Johnson & Johnson | 496.44B |
| AbbVie | 405.63B |
| UnitedHealth Group | 289.01B |
| AstraZeneca | 283.06B |
| Merck & Co. | 249.20B |
| Novartis AG | 244.50B |
| Abbott Laboratories | 221.17B |